Eli Lilly: expands collaboration with cancer institute
(CercleFinance.com) - Eli Lilly has entered into an agreement with Dana-Farber Cancer Institute to expand their collaboration into new cancer treatments for another three years.
Since 2015, scientists from Lilly and Dana-Farber had been working together on pre-clinical and clinical studies, and molecular analyses of patient samples to help advance cancer care.
All compounds evaluated through this collaboration will continue to be fully owned by Lilly.
The financial terms of this agreement have not been disclosed.
Copyright (c) 2018 CercleFinance.com. All rights reserved.
Since 2015, scientists from Lilly and Dana-Farber had been working together on pre-clinical and clinical studies, and molecular analyses of patient samples to help advance cancer care.
All compounds evaluated through this collaboration will continue to be fully owned by Lilly.
The financial terms of this agreement have not been disclosed.
Copyright (c) 2018 CercleFinance.com. All rights reserved.